- call +1-201-465-4211
- email sales@mrinsights.biz
Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. There are four basic types of bipolar disorder; all of them involve clear changes in mood, energy, and activity levels.
Scope of the Report:
This report studies the Bipolar Disorder market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Bipolar Disorder market by product type and applications/end industries.
People suffering with bipolar disorder have intense emotional states that occur in distinct periods called mood episodes. Mood episode is characterized by drastic changes in person’s usual mood and their behavior. Mood episode is mainly classified into two main types: manic episodes and depressive episodes. An overexcited or joyful state is called a manic episode and an extremely hopeless or sad state is called a depressive episode. Sometimes, a mood episode includes symptoms of both depression and mania, known as mixed state. These mood episodes hamper school and job performance.
The global Bipolar Disorder market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Bipolar Disorder.
Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.
Market Segment by Companies, this report covers
Glaxo SmithKline (GSK)
Pfizer
Janssen Pharmaceuticals
Eli Lilly
Allergan
Novartis
AbbVie
Otsuka
AstraZeneca
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitors
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Benzodiazepines
Beta Blockers
Market Segment by Applications, can be divided into
Mood Stabilizers
Anticonvulsants
Antipsychotic drugs
Antidepressant drugs
Antianxiety drugs
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Bipolar Disorder Market Overview
1.1 Product Overview and Scope of Bipolar Disorder
1.2 Classification of Bipolar Disorder by Types
1.2.1 Global Bipolar Disorder Revenue Comparison by Types (2017-2023)
1.2.2 Global Bipolar Disorder Revenue Market Share by Types in 2017
1.2.3 Selective Serotonin Reuptake Inhibitor
1.2.4 Serotonin Norepinephrine Reuptake Inhibitors
1.2.5 Tricyclic Antidepressants
1.2.6 Monoamine Oxidase Inhibitors
1.2.7 Benzodiazepines
1.2.8 Beta Blockers
1.3 Global Bipolar Disorder Market by Application
1.3.1 Global Bipolar Disorder Market Size and Market Share Comparison by Applications (2013-2023)
1.3.2 Mood Stabilizers
1.3.3 Anticonvulsants
1.3.4 Antipsychotic drugs
1.3.5 Antidepressant drugs
1.3.6 Antianxiety drugs
1.4 Global Bipolar Disorder Market by Regions
1.4.1 Global Bipolar Disorder Market Size (Million USD) Comparison by Regions (2013-2023)
1.4.1 North America (USA, Canada and Mexico) Bipolar Disorder Status and Prospect (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy) Bipolar Disorder Status and Prospect (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Bipolar Disorder Status and Prospect (2013-2023)
1.4.4 South America (Brazil, Argentina, Colombia) Bipolar Disorder Status and Prospect (2013-2023)
1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Bipolar Disorder Status and Prospect (2013-2023)
1.5 Global Market Size of Bipolar Disorder (2013-2023)
2 Manufacturers Profiles
2.1 Glaxo SmithKline (GSK)
2.1.1 Business Overview
2.1.2 Bipolar Disorder Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Glaxo SmithKline (GSK) Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.2 Pfizer
2.2.1 Business Overview
2.2.2 Bipolar Disorder Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Pfizer Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.3 Janssen Pharmaceuticals
2.3.1 Business Overview
2.3.2 Bipolar Disorder Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Janssen Pharmaceuticals Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli Lilly
2.4.1 Business Overview
2.4.2 Bipolar Disorder Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli Lilly Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.5 Allergan
2.5.1 Business Overview
2.5.2 Bipolar Disorder Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Allergan Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Bipolar Disorder Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.7 AbbVie
2.7.1 Business Overview
2.7.2 Bipolar Disorder Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 AbbVie Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.8 Otsuka
2.8.1 Business Overview
2.8.2 Bipolar Disorder Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Otsuka Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
2.9 AstraZeneca
2.9.1 Business Overview
2.9.2 Bipolar Disorder Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 AstraZeneca Bipolar Disorder Revenue, Gross Margin and Market Share (2016-2017)
3 Global Bipolar Disorder Market Competition, by Players
3.1 Global Bipolar Disorder Revenue and Share by Players (2013-2018)
3.2 Market Concentration Rate
3.2.1 Top 5 Bipolar Disorder Players Market Share
3.2.2 Top 10 Bipolar Disorder Players Market Share
3.3 Market Competition Trend
4 Global Bipolar Disorder Market Size by Regions
4.1 Global Bipolar Disorder Revenue and Market Share by Regions
4.2 North America Bipolar Disorder Revenue and Growth Rate (2013-2018)
4.3 Europe Bipolar Disorder Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Bipolar Disorder Revenue and Growth Rate (2013-2018)
4.5 South America Bipolar Disorder Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Bipolar Disorder Revenue and Growth Rate (2013-2018)
5 North America Bipolar Disorder Revenue by Countries
5.1 North America Bipolar Disorder Revenue by Countries (2013-2018)
5.2 USA Bipolar Disorder Revenue and Growth Rate (2013-2018)
5.3 Canada Bipolar Disorder Revenue and Growth Rate (2013-2018)
5.4 Mexico Bipolar Disorder Revenue and Growth Rate (2013-2018)
6 Europe Bipolar Disorder Revenue by Countries
6.1 Europe Bipolar Disorder Revenue by Countries (2013-2018)
6.2 Germany Bipolar Disorder Revenue and Growth Rate (2013-2018)
6.3 UK Bipolar Disorder Revenue and Growth Rate (2013-2018)
6.4 France Bipolar Disorder Revenue and Growth Rate (2013-2018)
6.5 Russia Bipolar Disorder Revenue and Growth Rate (2013-2018)
6.6 Italy Bipolar Disorder Revenue and Growth Rate (2013-2018)
7 Asia-Pacific Bipolar Disorder Revenue by Countries
7.1 Asia-Pacific Bipolar Disorder Revenue by Countries (2013-2018)
7.2 China Bipolar Disorder Revenue and Growth Rate (2013-2018)
7.3 Japan Bipolar Disorder Revenue and Growth Rate (2013-2018)
7.4 Korea Bipolar Disorder Revenue and Growth Rate (2013-2018)
7.5 India Bipolar Disorder Revenue and Growth Rate (2013-2018)
7.6 Southeast Asia Bipolar Disorder Revenue and Growth Rate (2013-2018)
8 South America Bipolar Disorder Revenue by Countries
8.1 South America Bipolar Disorder Revenue by Countries (2013-2018)
8.2 Brazil Bipolar Disorder Revenue and Growth Rate (2013-2018)
8.3 Argentina Bipolar Disorder Revenue and Growth Rate (2013-2018)
8.4 Colombia Bipolar Disorder Revenue and Growth Rate (2013-2018)
9 Middle East and Africa Revenue Bipolar Disorder by Countries
9.1 Middle East and Africa Bipolar Disorder Revenue by Countries (2013-2018)
9.2 Saudi Arabia Bipolar Disorder Revenue and Growth Rate (2013-2018)
9.3 UAE Bipolar Disorder Revenue and Growth Rate (2013-2018)
9.4 Egypt Bipolar Disorder Revenue and Growth Rate (2013-2018)
9.5 Nigeria Bipolar Disorder Revenue and Growth Rate (2013-2018)
9.6 South Africa Bipolar Disorder Revenue and Growth Rate (2013-2018)
10 Global Bipolar Disorder Market Segment by Type
10.1 Global Bipolar Disorder Revenue and Market Share by Type (2013-2018)
10.2 Global Bipolar Disorder Market Forecast by Type (2018-2023)
10.3 Selective Serotonin Reuptake Inhibitor Revenue Growth Rate (2013-2023)
10.4 Serotonin Norepinephrine Reuptake Inhibitors Revenue Growth Rate (2013-2023)
10.5 Tricyclic Antidepressants Revenue Growth Rate (2013-2023)
10.6 Monoamine Oxidase Inhibitors Revenue Growth Rate (2013-2023)
10.7 Benzodiazepines Revenue Growth Rate (2013-2023)
10.8 Beta Blockers Revenue Growth Rate (2013-2023)
11 Global Bipolar Disorder Market Segment by Application
11.1 Global Bipolar Disorder Revenue Market Share by Application (2013-2018)
11.2 Bipolar Disorder Market Forecast by Application (2018-2023)
11.3 Mood Stabilizers Revenue Growth (2013-2018)
11.4 Anticonvulsants Revenue Growth (2013-2018)
11.5 Antipsychotic drugs Revenue Growth (2013-2018)
11.6 Antidepressant drugs Revenue Growth (2013-2018)
11.7 Antianxiety drugs Revenue Growth (2013-2018)
12 Global Bipolar Disorder Market Size Forecast (2018-2023)
12.1 Global Bipolar Disorder Market Size Forecast (2018-2023)
12.2 Global Bipolar Disorder Market Forecast by Regions (2018-2023)
12.3 North America Bipolar Disorder Revenue Market Forecast (2018-2023)
12.4 Europe Bipolar Disorder Revenue Market Forecast (2018-2023)
12.5 Asia-Pacific Bipolar Disorder Revenue Market Forecast (2018-2023)
12.6 South America Bipolar Disorder Revenue Market Forecast (2018-2023)
12.7 Middle East and Africa Bipolar Disorder Revenue Market Forecast (2018-2023)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
List of Tables and Figures
Figure Bipolar Disorder Picture
Table Product Specifications of Bipolar Disorder
Table Global Bipolar Disorder and Revenue (Million USD) Market Split by Product Type
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
